
Corporate
Anika Therapeutics CEO Blanchard Steps Down After Turbulent 6-Year Tenure; CFO Griffin Takes Helm
Jan 8
You're signed outSign in or to get full access.
Browse quarterly earnings call transcripts for Anika Therapeutics.
Feb 26, 2026
Nov 5, 2025
Jul 30, 2025
May 9, 2025
Mar 12, 2025
Oct 31, 2024
Aug 8, 2024
May 8, 2024
Mar 13, 2024
Nov 2, 2023
Aug 8, 2023